Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Vonoprazan Pharmacology – New Esophagitis Medication Class! Episode 326

05.09.2024 - By Eric Christianson, PharmD; Pharmacology Expert and Clinical PharmacistPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

On this episode, I discuss the new medication vonoprazan and where it will likely be used in practice.

Vonoprazan is from a brand new class of medication called "PCAB". I discuss this medication and its pharmacology in this podcast episode.

Drug interactions and cost are the two major downsides of this medication that will likely limit its use compared to the PPIs.

CYP3A4 inducers like rifampin, carbamazepine, and phenytoin should not be used with vonoprazan. They will reduce the effectiveness of vonoprazan.

More episodes from Real Life Pharmacology - Pharmacology Education for Health Care Professionals